CRISPR in Drug Discovery 2021
Merck KGaA

Where: 06
Merck KGaA’s Sigma-Aldrich® CRISPR and Advanced Genomics portfolio delivers complete support for every step of genome engineering and drug discovery. Research to reality, discovery to therapeutic impact. We navigate the entire process so you can, too. We offer the largest portfolio of off the shelf and custom CRISPR libraries, pools, and individual clones so you can knockout, knockdown, and overexpress your genes with pooled and arrayed solutions.

With nearly two decades of gene editing expertise, world class lentiviral manufacturing and R&D, and over 300,000 products to complete your entire experimental workflow, we are committed to helping you solve the toughest challenges in life science. To learn more please visit SigmaAldrich.com.
Tel: +44 7766 241396
Address: Frankfurter Strasse 250
Website: https://www.sigmaaldrich.com/united-kingdom.html
Email:

Staff Attending

Dr Gurpreet Balrey
EMEA bus head, Genome Engineering
Merck
Mrs Rachel Henry
CRISPR Marketing Manager
Merck KGaA
United States
Dr Rachel Macmaster
Marketing Manager
Merck KGaA
France
Dr Andrew Ravanelli
Principal R&D Scientist
Merck KGaA
United States